
Myosit Plus150 mg+550
Renata Limited
Established / Guideline-Supported Use Polycystic Ovary Syndrome (PCOS): D-chiro-inositol + Myo-inositol is commonly used and more.
Important: This is not an FDA-approved prescription medicine; evidence supporting its use is more limited than for conventional pharmacotherapy. D-chiro-inositol + Myo-inositol should be used as directed by a physician and is not a substitute for prescribed treatment where one is indicated.
D-chiro-inositol + Myo-inositol dosing should be individualized and guided by a physician. A commonly studied and used regimen for PCOS-related insulin resistance is a formulation providing myo-inositol and D-chiro-inositol in a 40:1 ratio, taken twice daily by mouth.
| Indication | Typical Adult Dose |
|---|---|
| PCOS / insulin resistance support | D-chiro-inositol + Myo-inositol providing approximately 2000 mg myo-inositol + 50 mg D-chiro-inositol (40:1 ratio), taken twice daily (total approx. 4000 mg myo-inositol + 100 mg D-chiro-inositol per day) |
| Pediatric / adolescent use | Safety and efficacy not established; use only under specialist supervision if considered |
| Renal or hepatic impairment | No well-established dose adjustment; use with caution and physician guidance |
D-chiro-inositol + Myo-inositol is typically supplied as an oral powder sachet (dissolved in a glass of water), capsule, or tablet. It may be taken with or without food, though taking it with meals may reduce the chance of mild gastrointestinal upset. Doses are usually spaced approximately 12 hours apart (e.g. once in the morning and once in the evening). It should be taken consistently as directed by a physician for the recommended duration to assess benefit.
D-chiro-inositol + Myo-inositol is generally well tolerated. When side effects occur, they are usually mild and dose-related, most commonly involving the gastrointestinal tract:
Serious adverse effects are rare. Patients who experience severe or persistent symptoms should stop use of D-chiro-inositol + Myo-inositol and consult a physician.
D-chiro-inositol + Myo-inositol is contraindicated in individuals with known hypersensitivity to myo-inositol, D-chiro-inositol, or any excipient in the specific product formulation. No other well-established absolute contraindications have been identified in the available literature.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.